Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors by Raveh, Barak et al.
Rosetta FlexPepDock ab-initio: Simultaneous Folding,
Docking and Refinement of Peptides onto Their
Receptors
Barak Raveh
1,2, Nir London
1, Lior Zimmerman
1, Ora Schueler-Furman
1*
1Department of Microbiology and Molecular Genetics, Hadassah Medical School, Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem, Israel,
2The Blavatnik School of Computer Science, Tel-Aviv University, Tel-Aviv, Israel
Abstract
Flexible peptides that fold upon binding to another protein molecule mediate a large number of regulatory interactions in
the living cell and may provide highly specific recognition modules. We present Rosetta FlexPepDock ab-initio, a protocol
for simultaneous docking and de-novo folding of peptides, starting from an approximate specification of the peptide
binding site. Using the Rosetta fragments library and a coarse-grained structural representation of the peptide and the
receptor, FlexPepDock ab-initio samples efficiently and simultaneously the space of possible peptide backbone
conformations and rigid-body orientations over the receptor surface of a given binding site. The subsequent all-atom
refinement of the coarse-grained models includes full side-chain modeling of both the receptor and the peptide, resulting
in high-resolution models in which key side-chain interactions are recapitulated. The protocol was applied to a benchmark
in which peptides were modeled over receptors in either their bound backbone conformations or in their free, unbound
form. Near-native peptide conformations were identified in 18/26 of the bound cases and 7/14 of the unbound cases. The
protocol performs well on peptides from various classes of secondary structures, including coiled peptides with unusual
turns and kinks. The results presented here significantly extend the scope of state-of-the-art methods for high-resolution
peptide modeling, which can now be applied to a wide variety of peptide-protein interactions where no prior information
about the peptide backbone conformation is available, enabling detailed structure-based studies and manipulation of those
interactions.
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Introduction
Peptide-mediated interactions with globular proteins play a
prominent role in signaling and regulatory networks of the living
cell [1,2]. It has been estimated that between 15%-40% of all
protein-protein interactions are mediated by flexible peptide that
fold upon binding to a globular receptor [2]. These peptides often
form a modular binding motif, which can be embedded in
intrinsically unstructured protein regions and within flexible loops,
in order to confer desired interactions [2,3,4,5].
Due to their cardinal role in regulatory mechanisms (e.g. [6]),
flexible peptides are implicated in human disease and cancer [1],
and therefore provide attractive leads for the design of inhibitory
peptides and small molecule drugs [7,8,9,10,11,12]. A large-scale
in-silico survey that we conducted recently suggests that peptides
derived from globular proteins often have the potential to disrupt
interactions of their origin domains by competitive inhibition [13],
as was previously shown in experiment in several physiological
interactions [14,15]. Hence, peptide molecules and their derivates
hold great potential for targeted modulation of the cellular
network of protein interactions.
Available structural models of peptide-protein interactions
obtained by X-ray and NMR experiments have contributed
significantly to our understanding of the mechanisms underlying
key cellular interactions [9,16,17,18], and enabled the structure-
based redesign of both the peptide and receptor sequence at the
binding site to inhibit specific cellular interactions altogether
[10,11]. However, the number of available models solved in
experiment represents only a small fraction of known peptide-
protein interactions, while high-throughput methods for screening
of peptide libraries suchas peptide arrays [19] combinatorial phage-
display [20,21,22] and yeast surface display [23,24,25] continue to
produce aneverincreasing flux of data about newpeptide-mediated
interactions whose structural basis is mostly poorly understood.
We have recently introduced Rosetta FlexPepDock [26], a
protocol for the refinement of coarse models of peptide-protein
complex structures. We benchmarked FlexPepDock thoroughly to
define an effective basin of attraction of 5.5 A ˚ RMSD from which
the protocol can reliably recover near native peptide conforma-
tions. This covers a wide range of real world biological problems,
for which an initial approximate structure is available. Indeed,
we have used this protocol to model the structure of different
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role (e.g. [27,28,29]). However, refinement is effective only if the
approximate peptide backbone conformation within the receptor-
binding site is given. Other methods dedicated to peptide docking
have recently been developed but seem to be rather local as well
[30,31,32], or restricted to very short peptides [33,34].
In this study, we introduce Rosetta FlexPepDock ab-initio, which
is designed to addressthe subsetofproblemswhere the approximate
location of the peptide binding site is known, but no information
about the peptide backbone conformation is available. The
approximate binding site of the peptide can often be obtained
from cross-linking experiments, mutational analysis, NMR shifts or
any other experimental evidence [35,36], and from computational
predictions of increasingquality [37]. FlexPepDockab-initioborrows
from existing Rosetta protocols, and attempts to ‘fold’ the peptide at
the bindingsite, using fragment-based sampling to detect the overall
conformation of the peptide in a reduced representation space
(centroid mode) [38], coupled with efficient scanning of peptide
orientations over the protein surface. This step is then followed by
all-atom refinement of the peptide-protein conformation with fine
backbone modeling and side-chain placement, based on the Rosetta
FlexPepDock refinement protocol [26].
In the following sections, we present the Rosetta FlexPepDock
ab-initio protocol, its usage and workflow and its performance on a
selected benchmark of peptide-protein complexes. We anticipate
that the new protocol will significantly contribute to the study of
peptide-protein interactions, both for the purpose of basic research
and for the increasing use of peptides for pharmaceutical
applications.
Methods
Fig. 1 shows a schematic view of the FlexPepDock ab-initio
protocol. Each step is described in more detail below.
Preliminary steps prior to running the protocol
Input model. The input to the protocol is an initial model of
the peptide-protein complex. It is assumed that the receptor
backbone is approximately correct, and that the peptide is initially
positioned close to the correct binding site, albeit with arbitrary
backbone conformation (the present study is based on results starting
from extended peptide backbone conformations superimposed on a
randomly selected anchor residue, but the protocol is designed to
work from any arbitrarypeptide starting conformation; see below and
Table S3). Initial side-chain coordinates (such as the crystallographic
side-chains of an unbound receptor) can be optionally provided as
part of the input model, but are not required. In our analysis, we
discarded the input side-chains from native complexes in the bound
runs, but kept the side-chains from the free receptor structures in the
unbound runs.
Preparation of fragment library for peptide. For efficient
sampling of the peptide backbone, we generate a library of trimer,
pentamer and nonamer backbone fragments, which are extracted
from solved protein structures in the Protein Data Bank (PDB at
www.pdb.org [39]), using the protocol described in this issue by
Gront et al. The library is constructed based on sequence similarity
to the query peptide and on the secondary structure predicted for
the peptide by PSIPRED [40], resultingin 500 fragments from each
category of secondary structure type, i.e., a helix, extended b strand
and coiled-coil loop (with a total of 1,500 fragments for a given
query peptide). We note that although PSIPRED was not optimized
for peptides, the resulting fragment libraries showed in practice
good coverage of the peptide conformational space (in concordance
with a recent report by Vanhee et al. that most peptide-protein
interactions can be represented by fragment sets derived from
single, non-related monomer structures [17]). We also note that
fragments used in this analysis were not taken from the native
peptide structure or any of its homologues (in fact, only fragments
from globular monomer proteins were considered).
Figure 1. General outline of the Rosetta FlexPepDockab-initio protocol. See Text for more details.
doi:10.1371/journal.pone.0018934.g001
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archive:
scripts/prep_abinitio.sh pdb-id
Prepacking step -remove internal clashes in receptor. A
first preliminary step in our protocol involves the packing of the
side-chains in each monomer to remove internal clashes that are
not related to inter-molecular interactions, as described in Raveh
et al. [26].
The pre-packing stage guarantees a uniform conformational
background in non-interface regions, prior to molecular docking
[41]. We refer to the pre-packed input structure as the starting
structure.
See the FlexPepDockAbInitio protocol capture
archive:
$PATH_TO_EXE/FlexPepDocking.linuxgccrelease
-database $PATH_TO_DB –s start.pdb -native
native.pdb -ex1 -ex2aro -use_input_sc -unboun-
drot native.pdb -flexpep_prepack -nstruct 1
Step I: generation of models
We generate a large number of models beginning from the
starting structure by repeating the procedure described below over
multiple independent runs (which can be performed in parallel on
a CPU cluster). In the present study we generated 50,000 models
from each starting structure. More models can improve sampling
and results further.
Step Ia – fast low-resolution modeling. In a first step, the
peptide is folded and docked over the surface of the receptor protein
using a low-resolution representation of the complex, in which the
side-chains are represented as unified spheres (Rosetta centroid
mode [38]). The peptide is alternately folded and docked for 10
outer cycles. Each such outer-cycle consists of two internal Monte-
Carlo simulations. The temperature term of the Metropolis
criterion in the internal simulations is gradually decreased from
2.0 in the first outer cycle to 0.6 (arbitrary units) in the last outer
cycle, such that large perturbations are favored in the first rounds.
The inner simulations consist of: (1) Optimization of the rigid-body
orientation: The peptide rigid-body orientation is optimized by a
Monte-Carlo simulation consisting of 50 random rigid-body
transformations (translational magnitude of 1 A ˚ and rotational
magnitude of 10u on average in each step). (2) Optimization of the
peptide-backbone: The ab initio sampling protocol of the peptide
backbone is performed based on moves described in detail in Rohl
et al. [38]. In short, the peptide backbone conformation is perturbed
over 50 random Monte-Carlo moves while the peptide rigid body
orientation remains fixed. Each move is selected randomly. In 60%
of the moves, the Q/y torsion angles of random residues are
perturbed using the so-called ‘small’ and ‘shear’ random moves
described in Rohl et al. [38], to random magnitude, corresponding
for the ‘small’ moves to random changes in Q/y angles. In the shear
moves, the Q angle is rotated with equal magnitude but opposite
direction relative to the preceding y angle, thereby reducing the
perturbation to the rest of the chain. For both moves, perturbations
to non-favorable Ramachandran angles are discriminated against,
using a Metropolis criterion. In the remaining 40% of the moves, a
trimer (30% of cases), pentamer (7.5% of cases) or a nonamer (2.5%
of cases; for peptides with nine residues or more) fragment from the
fragment library is inserted in a random position within the peptide.
Step Ib – refinement of low-resolution model. The low-
resolution modeling step results in a coarse-grained model of the
peptide-protein complex. This model is further optimized using
high-resolution refinement with the Rosetta FlexPepDock
refinement protocol [26]. This protocol was shown to be
effective when the initial peptide conformation lies up to 5.5 A ˚
from the native conformation. In brief, it consists of alternating
optimization of the peptide rigid-body and backbone and
orientation using the Monte-Carlo with Minimization approach
[42] and a set of small-scale perturbations. To allow significant
perturbations within the binding pocket while preventing the
peptide and protein to separate during energy minimization, the
refinement step begins with decreased and increased weights for
the repulsive and attractive van der Waals term in the energy
function, respectively. During refinement, these terms are
gradually ramped back towards their original values.
See the FlexPepDockAbInitio protocol capture
archive:
$PATH_TO_EXE/FlexPepDocking.linuxgccre-
lease -database $PATH_TO_DB
#io flags:
-s start.ppk.pdb
-native native.pdb
-out:file:silent_struct_type binary
-out:file:silentdecoys.silent
-scorefile score.sc
#If using multiple processes and no silent
file:
#-multiple_processes_writing_to_one_direc-
tory
#number of structures to produce
#for demo:
-nstruct 5
#for production run:
#-nstruct 50000
#flexpepdock flags:
-rbMCM
-torsionsMCM
-flexPepDocking:lowres_abinitio
-flexPepDocking:flexpep_score_only
#packing flags
-ex1
-ex2aro
-use_input_sc
-unboundrot native.pdb
#fragment picker flags:
-frag3 frags/frags.3mers.offset
-frag9 frags/frags.9mers.offset
-flexPepDocking:frag5 frags/frags.5mers.
offset
-flexPepDocking:frag5_weight 0.25
-flexPepDocking:frag9_weight 0.1
Step II: selection of models
In addition to sampling the conformational energy landscape
efficiently, the challenge of modeling includes also the selection of
the correct model among all the created models, which can be
illustrated by the notion of finding a needle in a haystack. In order
to do so, we first cluster our top-scoring models, and subsequently
select top-scoring clusters as a model for the interaction. The top
scoring 500 models are clustered using the Rosetta Cluster
application, as described in Gray et al. [41], with a cluster radius
cutoff of 2 A ˚ peptide backbone atom RMSD. From each cluster, a
representative model is subsequently selected according to the best
energy score. The clusters are then ranked according to the energy
of their representative models.
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archive:
scripts/clustering/cluster.shpdb-idtopXrms-
radius scorefile reference-pdb models-silent-
file score-type
Benchmarking of protocol
Datasets of peptide–protein interactions. Since the
FlexPepDock ab-initio simulations are time intensive, we selected
a small but representative subset of complexes on which to assess
the protocol. The bound dataset used in this study includes 26
peptide–protein complex structures (Table S1) chosen from the
peptiDB dataset [9], a non-redundant set of high-resolution
peptide–protein complex structures (below 70% sequence identity
between receptor proteins; structures solved at resolution of 2 A ˚ or
better). These peptide-protein complexes represent a wide range of
biological contexts. Besides a few interactions with a known and
well-defined motif (PDB ids: 1SSH, 1W9E, 1Z90 and 2P1K), the
interactions in this dataset were selected randomly. The length of
peptides in the dataset varies between 5 and 13 amino acids, with
up to 52 rotatable bonds. More details about these complexes can
be found in Table S1.
Unbound dataset. For 14 out of the 26 complexes tested in
this study, a high resolution (,2A ˚) free receptor structure has
been solved (or that of a protein with .90% sequence identity).
The unbound structures were also extracted from the peptiDB
dataset [9] and their interface residues were superimposed onto
their bound counterparts as described in London et al. [9], to
evaluate the difference between the free and bound receptor
(Table S1). We note that in our benchmarking analysis, we
discarded the input side-chains from native complexes only for
docking to bound receptor structures, but not to free receptor
Table 1. Benchmark of FlexPepDock ab-initio.
(A) Bound PDB id Sec str
Start backbone-
RMSD
#
Start Q/y
RMSD
#
Best backbone-
iRMSD{
Top-10 backbone-
iRMSD{
Rank of first
near-native
cluster
Hexamer all-atom
top-10
*
1NVR
a b + C 1.2 A ˚ 23u 0.2 A ˚ 0.5 A ˚ 1 0.9 A ˚b
2FMF
c A1 6 . 1 A ˚ 131u 0.4 A ˚ 0.5 A ˚ 7 0.6 A ˚
2O9V
c C 5.5 A ˚ 49u 0.4 A ˚ 0.6 A ˚ 1 0.4 A ˚
2P1K b + C 6.1 A ˚ 61u 0.5 A ˚ 0.6 A ˚ 1 0.6 A ˚
1RXZ b + C 8.9 A ˚ 80u 0.7 A ˚ 0.7 A ˚ 1 0.9 A ˚
2R7G a + C1 1 . 2 A ˚ 106u 0.8 A ˚ 0.8 A ˚ 7 1.1 A ˚
1AWR C 5.3 A ˚ 57u 0.8 A ˚ 0.9 A ˚ 1 1.6 A ˚
2FNT C 1.4 A ˚ 47u 0.4 A ˚ 1.0 A ˚ 1 2.0 A ˚
3D1E C 1.6 A ˚ 67u 0.7 A ˚ 1.1 A ˚ 1 1.3 A ˚
2B1Z A 8.9 A ˚ 124u 0.4 A ˚ 1.2 A ˚ 1 2.2 A ˚
1T7R A1 3 . 4 A ˚ 128u 0.7 A ˚ 1.2 A ˚ 3 0.8 A ˚
1N7F
c b + C 3.8 A ˚ 52u 0.3 A ˚ 1.4 A ˚ 1 0.8 A ˚
1ER8 C 6.0 A ˚ 52u 0.8 A ˚ 1.4 A ˚ 1 1.9 A ˚
1W9E b + C 1.2 A ˚ 39u 0.5 A ˚ 1.5 A ˚ 1 2.7 A ˚b
2VJ0 C 5.3 A ˚ 72u 1.2 A ˚ 1.5 A ˚ 1 1.4 A ˚
1Z9O C 6.9 A ˚ 56u 1.6 A ˚ 1.6 A ˚ 2 1.4 A ˚
2P54 a + C1 3 . 0 A ˚ 120u 0.8 A ˚ 1.8 A ˚ 2 2.2 A ˚
1NLN b + C1 1 . 7 A ˚ 27u 0.7 A ˚ 2.0 A ˚ 5 1.7 A ˚
2A3I
c a + C1 7 . 3 A ˚ 115u 0.7 A ˚ 2.1 A ˚ 314 2.2 A ˚
1SSH C 8.4 A ˚ 50u 0.9 A ˚ 3.1 A ˚ 51 2.7 A ˚
2J6F C 7.4 A ˚ 44u 1.7 A ˚ 5.7 A ˚ .500 7.2 A ˚
1KL3 a + C 9.4 A ˚ 93u 0.9 A ˚ 5.8 A ˚ .500 6.5 A ˚
1TW6 C 3.3 A ˚ 46u 1.8 A ˚ 5.9 A ˚ .500 6.5 A ˚
2C3I C1 3 . 0 A ˚ 70u 1.5 A ˚ 6.0 A ˚ 308 4.7 A ˚
2FGR
c C 7.3 A ˚ 79u 1.3 A ˚ 8.6 A ˚ .500 8.6 A ˚
1QKZ C 13.51A ˚ 78u 3.1 A ˚ 8.8 A ˚ None 4.5 A ˚
Performance of peptide modeling onto Bound (A) and Unbound (B) protein receptor structures.
The proteins in the benchmark are detailed in Table S1 (See Methods for more details).
#The start bb-RMSD and start Q/y RMSD refer to the distance between the initial peptide conformation at the beginning of the simulation and the native peptide
backbone.
{The best peptide backbone interface-RMSD among all 50,000 sampled models.
{The best peptide backbone interface-RMSD within the ten models representing the top clusters.
*The best all-atom RMSD of any partial hexamer of the peptide, among the ten top ranking models.
aPDBids in italics indicate complexes modeled also on the free receptor conformation (see Table 2).
bPentamer.
cComplexes described in accompanying Figures.
doi:10.1371/journal.pone.0018934.t001
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including side-chains of unbound receptors was shown in our
previous docking studies to improve protocol performance [26,43].
Measure of success. We define a docking model as near-
native if the interface backbone atoms of the predicted peptide
conformation deviate by #2A ˚ RMSD. For a docking simulation
of a given interaction, we define successful sampling as the cases where a
near-native model is sampled, and successful ranking as the cases where
a near-native model is ranked among the ten lowest-energy clusters.
Extending the peptide from a random anchor. For testing
the protocol starting from an extended peptide conformation, a
random peptide position was selected as an anchor (see Table S1
for details), and its coordinates were extracted from the native
complex. The peptide’s Q/y angles were then set to canonical
ideal extended conformation (+135u/2135u, respectively), from
which the docking simulations were initiated. We note that the
random anchor was not specified, and the peptide was completely
free to move during the simulation.
Random rigid-body perturbations. In order to evaluate
the robustness of FlexPepDock ab-initio, we repeated the run from
a different orientation, created by perturbation of the rigid-body
orientation of the extended peptide by random Gaussian
translations and rotations of magnitudes 3 A ˚ and 30u,
respectively. Docking experiments were then initiated from the
perturbed extended conformation.
Rosetta Revision. The protocol and tests described in this
manuscript follow the FlexPepDock protocol as implemented
within revision 39664 of the Rosetta repository.
Running time. A single simulation takes 2–4 minutes on a
single CPU over an AMD Sun cluster, depending on the size of
the receptor protein. Generation of the entire 50,000 models for a
single run takes approximately 24 hours on a cluster of 120
processors.
Rosetta infrastructure
As for the original FlexPepDock refinement protocol, the
FlexPepDock ab-initio protocol is fully implemented within the
Rosetta modeling framework [44]. Rosetta provides well-
calibrated energy functions, efficient energy calculations and a
battery of established conformational sampling protocols. In
particular, we use the Rosetta library of protein fragments
extracted from solved protein structures [38], the Monte-Carlo
sampling with Energy Minimization first proposed by Li
andScheraga [42], the Rosetta side-chain repacking protocol
[45] and the Dunbrackrotamer library [46]. For energy scoring,
we use a modified version of the Rosetta full-atom energy
function (Rosetta score12 [38,45], see below) and the coarse-
grained energy function, which employs a unified spheres side-
chains model (Rosetta centroid score4 [38]).
Energy function used for model selection
In our original FlexPepDock refinement study [26] we used the
standard Rosetta scoring function - score12 to rank and select the
top-scoring models. However, several previous docking studies
with Rosetta have indicated that the interface score, i.e. the energy
score across the interface (where only atom-atom contacts between
the partners are included in the energy evaluation) provides better
estimates by removing effects outside from the actual interface. In
addition, studies in our group on the prediction of binding
specificity have shown that the score of the peptide (i.e. the internal
peptide energy together with the interface energy) provides the
best estimate of binding (unpublished data). We therefore
investigated different energy terms for their ability to identify the
near-native models among the set of created models. The total
energy, interface energy, peptide energy, and a weighted sum of all
were assessed (see Table S2).
See the FlexPepDockAbInitio protocol capture
archive:
scripts/scoring/rescore.sh score.sc
Guide to installing and using the protocol
A detailed guide to the protocol with examples can be found as
a Protocol Capture archive named FlexPepDock Ab Initio.
Table 2. Benchmark of FlexPepDock ab-initio.
Unbound PDB id
Unbound
receptor
Ca- iRMSD Sec str
Start backbone-
RMSD
#
Start Q/y-
RMSD
#
Best backbone-
iRMSD{
Top-10
backbone-
iRMSD{
Rank of first
near-native
cluster
Hexamerall-atom
top-10
*
1NVR 0.3 A ˚ b + C 1.2 A ˚ 23u 0.2 A ˚ 0.4 A ˚ 2 1.1 A ˚b
2O9V
c 0.3 A ˚ C 5.5 A ˚ 49u 0.4 A ˚ 0.6 A ˚ 1 0.6 A ˚
1N7F
c 0.4 A ˚ b + C 3.8 A ˚ 52u 0.8 A ˚ 1.0 A ˚ 9 1.2 A ˚
2VJ0 0.3 A ˚ C 5.3 A ˚ 72u 1.2 A ˚ 1.4 A ˚ 8 1.8 A ˚
1AWR 0.3 A ˚ C 5.3 A ˚ 57u 0.9 A ˚ 1.4 A ˚ 2 2.0 A ˚
2A3I
c 0.3 A ˚ a + C1 7 . 3 A ˚ 115u 0.7 A ˚ 1.5 A ˚ 10 1.7 A ˚
1W9E 0.6 A ˚ b + C 1.2 A ˚ 39u 0.7 A ˚ 1.9 A ˚ 1 2.8 A ˚b
1T7R 0.4 A ˚ a 13.4 A ˚ 128u 0.7 A ˚ 2.6 A ˚ 28 4.1 A ˚
1SSH 0.7 A ˚ C 8.4 A ˚ 50u 1.1 A ˚ 3.2 A ˚ 22 4.2 A ˚
2C3I 0.2 A ˚ C1 3 . 0 A ˚ 70u 1.8 A ˚ 3.7 A ˚ 299 6.4 A ˚
1RXZ
c 1.5 A ˚ b + C 8.9 A ˚ 80u 1.9 A ˚ 4.3 A ˚ .500 2.1 A ˚
2FMF 0.5 A ˚ a 16.1 A ˚ 131u 0.4 A ˚ 5.0 A ˚ 29 3.5 A ˚
2P54 0.7 A ˚ a + C1 3 . 0 A ˚ 120u 2.2 A ˚ 9.7 A ˚ None 8.1 A ˚
2FGR
c 0.3 A ˚ C 7.3 A ˚ 79u 1.6 A ˚ 10.1 A ˚ .500 9.1 A ˚
Performance of peptide modeling onto Bound (A) and Unbound (B) protein receptor structures.
Legends as for Table 1.
doi:10.1371/journal.pone.0018934.t002
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I. General outline of Rosetta FlexPepDock ab-initio
protocol
The main components of our protocol for simultaneous ab-initio
folding and docking of flexible peptides are outlined in Fig. 1. In
short, after removing internal clashes of the receptor structure (by
repacking), we place the peptide into the binding site (here as an
extended conformation), and compile a corresponding library of
peptide backbone fragments. We then apply FlexPepDock ab-initio,
starting with low-resolution optimization of the peptide backbone
conformation and its rigid-body orientation, followed by high-
resolution refinement with full flexibility for all peptide and
receptor side-chains. The high-resolution step corresponds to our
previously developed Rosetta FlexPepDock refinement protocol
[26]. More details can be found in the Methods section.
II. Large-scale assessment of protocol performance
We assessed the ability of FlexPepDock ab-initio to sample and
identify the correct conformation of peptides on a benchmark of
26 different peptide-protein interactions extracted from the
PeptiDB dataset [9] (Table S1 and Methods). We created
n=50,000 conformations, starting from an extended peptide
within the binding site. The resulting models were clustered and
the clusters were ranked based on a reweighted version of the
Rosetta generic full-atom energy score, in which interface and
peptide residuesare given additional weight, and which improves
the performance of the protocol compared to the standard
Rosetta score (see Table S2 and Methods). Finally, we assessed
how many runs succeeded to identify near-native models (defined
as models with #2A ˚ peptide interface backbone RMSD in the
top 10 scoring clusters; see Methods). The performance of
FlexPepDock ab-initio is summarized in Table 1 (bound docking),
Table 2 (unbound docking) and Fig. 2, and specific examples are
presented in Fig. 3.
Simulations on the bound receptor conformation (Bound
docking). We first assessed the performance of the modeling
protocol on the bound backbone conformation of the receptor.
Successful modeling within this setup validates our strategy for
sampling peptide backbone conformations and rigid-body
orientations, and our energetic ranking ability within the setting
of an accurate receptor backbone structure. This setting is a
prerequisite for more realistic and challenging simulations
described below. The results of the bound docking benchmark
are summarized in Table 1 and Fig. 2A. In all but one case (25/
26; 96%), a near-native model of the interaction (as defined
above) was sampled by our protocol, and in most cases (18/26;
69%), the near-native model was also ranked within the ten top-
ranking clusters (top-ranked in 12/26; 46%). In half of the cases
(12/26) the backbone atoms of the top-ranking modeled
peptides were located within only one A ˚ngstrom RMSD of
the native peptide backbone. This is remarkable, as the peptide
backbones in the benchmark adopt diverse secondary structures
and backbone conformations, including unusual kinks, turns
and coils that are particularly hard to predict de-novo:T h e
starting backbone configurations include challenging cases
where the initial peptide backbone isup to 17 A ˚ away from
the native conformation, and the RMSD of the initially
extended peptide backbone from the native exceeds 125u in
Q/y torsion space.
Robustness of the FlexPepDock ab-initio protocol to
changes in starting conformation. In our evaluation
described above, we started from an extended peptide initially
positioned at the correct binding site, by aligning one of the
peptide residues to its native coordinates. Even though the peptide
was free to change its orientation and was not constrained in any
way during the simulation, it is important to validate the
robustness of our docking protocol to this initial orientation.
Therefore we reassessed performance by repeating the simulation
starting from a different conformation (see Methods). The results
indicate that our protocol is indeed robust to the precise initial
orientation of the extended peptide at the binding site, since the
results did not differ significantly among repeated runs (Table S3).
Even in the case where two simulations that from peptides
oriented in opposite directions, they converge onto one final
structure of the peptide-protein complex (see Fig. 4), leading the
way for fully blind peptide docking.
Comparison to peptide refinement protocol. The Flex-
PepDock ab-initio protocol uses our previously reported refinement
protocol [26] as a sub-module, but significantly extends its scope
thanks to a preceding low-resolution peptide ab-initiosampling step. In
particular, the new protocol does not assume any prior information
about the peptide backbone conformation, whereas the original
refinement protocol works well mainly when the initial peptide
conformation is within 5.5 A ˚ Cartesian- and 50u torsion-space
RMSD of the native conformation [26]. Indeed, the refinement
protocol is able to sample a near-native conformation in only 10 of
the 26 interactions (compared to 25/26 for theFlexPepDock ab-initio
protocol described here; Fig. 2A), and these 10 are the easier cases
where the native backbone conformation is already extended-like.
Hence, the low-resolution stage of the ab-initio protocol is able to turn
the harder cases into approximate models that can be refined to high-
resolution.
Simulations on the free receptor conformation (Unbound
docking). In realistic scenarios, the bound receptor is
obviously not part of the input when we try to dock a peptide
to its protein receptor, and only the receptor in its free form can
be used. The task of unbound docking is much more
challenging, as the backbone conformation of the receptor
protein may change upon binding, even though these changes
are often very small for peptide-protein interactions [9]. We
Figure 2. Summary of performance of FlexPepDock ab-initio on
a benchmark of peptide-protein complexes. The FlexPepDock ab-
initio protocol (Ab initio runs) samples a near-native structure in most
of the Bound (A) and Unbound (B) simulations (height of bars), and in a
significant fraction of the complexes a near-native structure is identified
by the top-ranking cluster, or among the top-2 or top-10 (shaded parts
of the bar; models clustered according to 2 A ˚ peptide backbone RMSD
cutoff). This significantly increases the scope FlexPepDock when
compared to the original refinement protocol (Refinement runs),
for both the Bound and Unbound simulations.
doi:10.1371/journal.pone.0018934.g002
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18934Figure 3. Examples of models created by the ab-initio FlexPepDock protocol. Bound (left panel) and Unbound (right panel) docking runs
are shown for three successful and one failed simulation (see Table 1 for the full dataset): (A) 2O9V (Ponsin SH3 domain -paxillin proline rich region
[51]); (B) 1N7F (GRIP1 PDZ6-liprin a c-terminal peptide complex [52]); (C) 2A3I (Mineralocorticoid ligand receptor domain - LXXLL motif of steroid
receptor coactivator-1 (SRC1-4) [53]); and (D) 2FGR (Omp32-PAP peptide [54]). For 2O9V, 1N7F and 2A3I, a near-native model was ranked among the
top 10 clusters for both the bound and unbound cases (the bound run of 2A3I is a borderline case, with 2.1A backbone interface RMSD). For each
complex, the receptor is shown in either lavender or gray shade, for the Bound or Unbound form, respectively. The cartoonre presentation shows the
peptide starting orientation (magenta), final model (red), and native structure (green). The corresponding energy landscape plots are shown for (A)
(see Fig. S1 for additional plots for all examples). Each model created by FlexPepDock ab-initio is plotted as a red cross according to its peptide
interface backbone RMSD (x-axis) and its energy score (y-axis; reweighted score; see Methods). The top 10 lowest energy clusters created from the
top 500 scoring models are shown as blue circles. The black line indicates the maximal energy of the top 500 models. The energy plots show a sub-
A ˚ngstrom lowest-energy cluster for both Bound and Unbound simulations. The black circles in the left panel show results from the previous
FlexPepDock refinement protocol [26], demonstrating how increased sampling allows the detection of conformations that have better energy scores
and are also more similar to the native structure.
doi:10.1371/journal.pone.0018934.g003
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receptor structure was available (Table S1). Again, in nearly all
cases at least one near-native model was sampled by our
protocol (12/14; 86%), and in half of the cases this model was
ranked among the ten top-ranking clusters (7/14; 50%) (see
T a b l e2 ;F i g .2 Ba n dr i g h tp a n e l si n Fig. 3), indicating that the
presented protocol is well suited for de-novo folding and docking
in many practical settings.
III. Partial success
Our protocol succeeded in modeling many of the complexes in
our benchmarks, but also failed in some cases. Manual inspection
of modeling failures revealed that in several of those, only part of
the peptide has been modeled at high resolution, resulting in
overall inaccurate models that do not meet the formal success
criterion. In some cases, these partially accurate models may still
be considered useful for practical applications. For instance, key
motif residues may be modeled particularly well, (see our previous
analysis in Raveh et al [26]), and other inaccuracies may be
introduced by intrinsic motility of flexible peptide tails, and effects
due to symmetry related contacts to the peptide that are not taken
into account in our simulations (see below). Here we describe
another case that involves partial conformational changes of the receptor
upon binding of the peptide.
The interaction of the C-terminal region of FEN-1 with PCNA
involvesa considerableconformational changethat redefinespart of
the receptor peptide binding site: upon peptide binding, an
intermolecular b-sheet interface is created between the two partners
(contributing to overall 1.5 A ˚ RMSD for interface Ca atoms
between the bound and free receptor conformation). This
conformational change has been suggested to explain how PCNA
stimulates FEN-1 activity. In the structure of PCNA bound toa
FEN-1C-terminalpeptide(PDBid1RXZ[47]),the peptideconsists
of two parts: a b-strand (residues 1–4) connected to a short 310 helix
(residues 7–11; note that the 310 helix is defined as a turn by
STRIDE [48]). The b-strand forms the intermolecular b sheet,
while the helix interacts with a region in the receptor that does not
change upon binding. Not surprisingly, while we succeed in
modeling the peptide conformation on the bound receptor
conformation at high accuracy (Table 1), the models based on the
free receptorconformationareonlypartlyaccurate(Table 2;Fig. 5):
they describe the helical part at high accuracy, including most of the
side-chain atoms (1.9 A ˚ all-atom RMSD over the five C-terminal
peptide residues for one of the top-10 models; Fig. 5), while the
strand is not formed due to the lack of the corresponding partner
strand in the receptor. This case demonstrates that even though the
overall quality of the peptide model does not pass our ‘formal’
threshold forsuccess,thereis stilla substructure that ismodeled very
accurately. Within the context of blind docking of the peptide
conformation onto a free receptor conformation, this substructure
could still serve as a useful starting point for subsequent peptide-
based design and manipulation of the interaction.
IV. Identification of new challenges
(1) Cases of accurate bound but inaccurate unbound
docking highlight importance of receptor flexibility for
peptide-protein interactions. While our protocol performs
well in half of the unbound cases, examples like 1RXZ (described
above and in Fig. 5) demonstrate the importance of including
receptor flexibility in peptide docking, which is an ongoing work in
our group. Even though the conformational changes of the receptor
upon binding of peptides are usually fairly small (Table 2 and [9]),
5/14 peptide-protein complexes were modeled and ranked
accurately only based on the bound receptor conformation, but
not based on the free receptor conformation. These cases will be
analyzed in more detail in a follow-up study and used to calibrate a
protocol that includes receptor backbone flexibility.
(2) Cases of inaccurate bound docking might be due to
crystal contacts that define the peptide conformation. We
observed that in several structures (in particular where we fail in
the simulations starting from the bound receptor structure), crystal
symmetry operations reveal additional contacts to the peptide that
are contributed by symmetry related molecules. These can
represent a considerable fraction of the overall contacts that the
peptide forms with its surrounding, and thus influence the
structure that the peptide will adopt. Since we do not account
for those contacts, our simulations might fail to accurately model,
or select, peptide models that resemble the native crystal structure
(e.g. we completely fail to identify the correct conformation for
PDB-id 2J6F [49]). This intriguing finding suggests that solved
peptide-protein complex structures might sometimes actually
represent non-biological conformations. We are currently
investigating in more detail how prevalent the influence of
symmetry-related molecules on the peptide conformation is, and
to what degree it affects our ability to identify and accurately
model the key features in the peptide-protein interface of
biological interactions.
(3) Towards blind peptide docking – integration with
binding site prediction tools. We demonstrated that the
present protocol is robust to the precise starting orientation of the
peptide near the binding site (Fig. 4 and Table S3). Therefore, we
foresee that it can be integrated with emerging techniques for
identifying ligand and peptide binding sites, based on the chemical
and the statistical features that characterize these sites (e.g.
[9,37,50]). This would enable blind docking of peptides without
any prior knowledge about either the binding site location or the
peptide backbone conformation. We anticipate that such a tool
will be applicable on a proteome-wide scale, and are working
towards this direction.
Figure 4. FlexPepDock ab-initio is robust to the initial starting
position of the peptide, and therefore opens up the way
towards fully blind peptide docking. The simulation of the
structure of the CheZ-derived peptide bound to CheY (PDB-id 2FMF
[55]) from two opposite starting orientations converge onto the same
final conformation. (A) General view of the receptor structure (in gray;
interface residues colored in light brown), the two initial extended
peptide conformations (in cartoons), and the final helical conformation
(in transparent cartoon). Peptide conformations are colored in rainbow.
(B) Detailed atomic view of the top predictions from the two
simulations (yellow and orange), highlighting the striking similarity of
both predictions to the structure of the native peptide (green).
doi:10.1371/journal.pone.0018934.g004
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We have presented a Rosetta protocol to efficiently model the
structure of a peptide bound to its receptor, using an optimization
scheme that involves simultaneous full ab initio sampling of the
peptide backbone conformation and its orientation on the receptor
protein. This computationally intensive protocol samples a
considerable conformation space, and consequently is able to
identify near-native models within the top-ranking clusters for
many challenging cases. These candidate structures provide an
excellent starting point for the subsequent characterization and
modulation of a peptide-mediated interaction: the atomic details of
the interaction are revealed, and further refinement with the
FlexPepDock refinement protocol described previously [26] can
identify peptide residues that contribute significantly to binding
affinity and specificity. This will significantly increase the number
of peptide-mediated interactions that can be accurately charac-
terized and manipulated.
Supporting Information
Figure S1 Energy landscape plots for models created
by the FlexPepDockab initio protocol. Energy plots for
Bound (left panel) and Unbound (right panel) docking runs are
shown for the three successful and one failed simulations shown
in Fig. 3 (see Table 1 for the full dataset). From top to bottom:
2O9V; 1N7F; 2A3I; and 2FGR. See Legend to Fig. 3 for more
details.
(TIF)
Table S1 The benchmark of peptide-protein interac-
tions used in this study.
(DOCX)
Table S2 Number of successful predictions based on
different scoring functions. Reweighted score (blue) performs
best. Results refer to detection of top-scoring models, prior to
clustering (see Methods for more details).
(DOCX)
Table S3 The FlexPepDockab-initio protocol is robust
to changes in starting conformation. Similar results are
obtained for two repeats of the protocol fromdistinct starting
structures. The two starting structures are the extended confor-
mation reported in Table 1 (in italics and parentheses), and an
initial peptide orientation obtained by random translation and
rotation of 3A and 30u, respectively).
(DOCX)
Figure 5. Redefining success. Partial accuracy due to a conformational change in the receptor in the interaction of the C-terminal region of FEN-1
with PCNA (PDB id 1RXZ [47]). (A) Structural view of this interaction in cartoon view: The free and bound conformations of the receptor are shown on
the left in blue and gray ribbon, respectively. The native peptide is shown in green cartoon, and two of the top-scoring models are shown in red and
pink. The C-terminal region of the receptor (highlighted) undergoes a conformational change upon binding to create a b-sheet pairing with the
native peptide (green cartoon). Therefore, while the helical region of the peptide (residues 7–11, see inset) is well modeled in top-ranking models, the
strand-part (residues 1–4) is not accurate. The inset on the right highlights the accurate recapitulation of certain atomic details in the helical peptide
part. (B) Energy plots of this interaction: Left panel: The plot of the full peptide demonstrates that no near-native conformations are sampled or
selected when considering the entire peptide sequence (peptide interface backbone RMSD, x-axis, vs. energy score, y-axis; same depiction as in Fig. 3).
Right panel: The plot for the best pentamer substructure of the peptide demonstrates high accuracy, which can be attributed to the helical part of
the peptide (note that this plot shows allatom RMSD).
doi:10.1371/journal.pone.0018934.g005
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